Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Postgrad Med J ; 100(1182): 209-218, 2024 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-38147883

RESUMEN

This article reviews the correlation between presepsin and sepsis and the resulting acute respiratory distress syndrome (ARDS). ARDS is a severe complication of sepsis. Despite the successful application of protective mechanical ventilation, restrictive fluid therapy, and neuromuscular blockade, which have effectively reduced the morbidity and mortality associated with ARDS, the mortality rate among patients with sepsis-associated ARDS remains notably high. The challenge lies in the prediction of ARDS onset and the timely implementation of intervention strategies. Recent studies have demonstrated significant variations in presepsin (PSEP) levels between patients with sepsis and those without, particularly in the context of ARDS. Moreover, these studies have revealed substantially elevated PSEP levels in patients with sepsis-associated ARDS compared to those with nonsepsis-associated ARDS. Consequently, PSEP emerges as a valuable biomarker for identifying patients with an increased risk of sepsis-associated ARDS and to predict in-hospital mortality.


Asunto(s)
Síndrome de Dificultad Respiratoria , Sepsis , Humanos , Sepsis/complicaciones , Sepsis/terapia , Síndrome de Dificultad Respiratoria/etiología , Síndrome de Dificultad Respiratoria/terapia , Respiración Artificial/métodos , Biomarcadores , Mortalidad Hospitalaria , Fragmentos de Péptidos , Receptores de Lipopolisacáridos
2.
Int Immunopharmacol ; 139: 112670, 2024 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-39018694

RESUMEN

Acute Respiratory Distress Syndrome (ARDS) manifests as an acute inflammatory lung injury characterized by persistent hypoxemia, featuring a swift onset, high mortality, and predominantly supportive care as the current therapeutic approach, while effective treatments remain an area of active investigation. Adrenergic receptors (AR) play a pivotal role as stress hormone receptors, extensively participating in various inflammatory processes by initiating downstream signaling pathways. Advancements in molecular biology and pharmacology continually unveil the physiological significance of distinct AR subtypes. Interventions targeting these subtypes have the potential to induce specific alterations in cellular and organismal functions, presenting a promising avenue as a therapeutic target for managing ARDS. This article elucidates the pathogenesis of ARDS and the basic structure and function of AR. It also explores the relationship between AR and ARDS from the perspective of different AR subtypes, aiming to provide new insights for the improvement of ARDS.


Asunto(s)
Agonistas de Receptores Adrenérgicos alfa 2 , Antagonistas Adrenérgicos beta , Síndrome de Dificultad Respiratoria , Sistema Nervioso Simpático , Humanos , Síndrome de Dificultad Respiratoria/tratamiento farmacológico , Animales , Antagonistas Adrenérgicos beta/uso terapéutico , Antagonistas Adrenérgicos beta/farmacología , Agonistas de Receptores Adrenérgicos alfa 2/uso terapéutico , Agonistas de Receptores Adrenérgicos alfa 2/farmacología , Sistema Nervioso Simpático/efectos de los fármacos , Sistema Nervioso Simpático/fisiopatología , Receptores Adrenérgicos/metabolismo , Transducción de Señal/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA